Search Insights

Insights

128 Insights found for Practices > Intellectual Property
TITLE
Event

A View from the Bench: The Federal Judges Speak on Paragraph IV Litigation

Paragraph IV Disputes Master Symposium – ACI’s Hatch-Waxman Series

Location:
Chicago, Ill.
Event

Obviousness at Another Glance: Exploring Secondary Considerations in ANDA Litigation

Paragraph IV Disputes Master Symposium – ACI’s Hatch-Waxman Series

Location:
Chicago, Ill.
Event

2018: A Year of Change for Post Issuance Proceedings

4th Annual IP Strategy Summit: Chicago

Location:
Chicago, Ill.
Event
Event
Event

ChiWIP’s Fourth Annual Post-Holiday Progressive Dinner

Chicago Women in IP

Location:
Chicago, Ill.
Event
Event

Girl Scout IP Patch Event

Chicago Women in IP

Location:
Chicago, Ill.
Event

Strategic Considerations When Managing and Protecting Disruptive Technologies

Managing Intellectual Property Innovation and Litigation Summit 2019

Location:
San Francisco , Calif.
In The News

Schiff Hardin Snags IP, Pharma Pro from Winston & Strawn

Law360The Wall Street JournalThomson ReutersBloomberg BusinessAmLaw DailyDeal Pipeline, LSIPR, IP Pro Life Sciences

In The News
News Release

Schiff Hardin Advises Client in Global M&A Network’s “U.S.A. ESOP Deal of the Year”

Schiff Hardin is pleased to have been counsel to E&M Ice Cream in a transaction that was recently awarded the “U.S.A. ESOP Deal of the Year” at the 2016 Americas M&A Atlas Awards by Global M&A Network.

News Release

Schiff Hardin Named One of 10 Firms “GCs Love for Pharma Work”

BTI’s Power Ranking 2016 recognized Schiff Hardin in its top category—Clientopia®—for the firm’s work on behalf of the pharmaceutical industry.

News Release

The Legal 500 Spotlights Three Schiff Hardin Practice Groups, Eight Attorneys

Schiff Hardin LLP is pleased to announce that three practice groups and eight attorneys have been recognized in the 2016 edition of the Legal 500.

In The News

Aly Quoted on Major SCOTUS Patent Venue Ruling

World Intellectual Property Review

In The News
In The News
In The News
News Release

Clients Recognize Schiff Hardin as a Top Firm in Pharma Two Years in a Row

For the second consecutive year, Schiff Hardin has been recognized as a top “Clientopia” law firm in the BTI Industry Power Rankings 2017.

News Release

Imron Aly Named Among Most Influential Minority Lawyers in Chicago

Schiff Hardin LLP is pleased to announce that Imron Aly, partner and Intellectual Property Group co-leader, has been recognized as a Most Influential Minority Lawyer in Chicago by Crain’s Chicago Business.

News Release

IP Practice Group Leader Recognized Among World’s Leading Patent Professionals

Schiff Hardin Intellectual Property Practice Group Co-Leader Imron Aly has been recognized as a leading patent litigator in Illinois in the 2017 IAM Patent 1000 guide, based on outstanding feedback from peers and clients.

News Release

Managing Intellectual Property Recommends Schiff Hardin, Highlights Three Attorneys

Schiff Hardin has been ranked “Highly Recommended” by Managing Intellectual Property magazine in the 2017 Illinois Patent Contentious category.

News Release

Muhammad Ali Enterprises Files Complaint in Federal Court in Chicago Against Fox Broadcasting Company for $30 Million

Today Muhammad Ali Enterprises filed a complaint in the United States District Court for the Northern District of Illinois against Fox Broadcasting Company seeking in excess of $30 million in damages for Fox’s unauthorized use of Muhammad Ali’s identity in a promotional video that Fox broadcast immediately before the start of Fox’s broadcast of the 2017 Super Bowl.

In The News
News Release

Schiff Hardin Expands Global Generic Pharmaceuticals Practice With Addition of Kevin M. Nelson in Chicago

Schiff Hardin LLP today announced the addition of Kevin M. Nelson as a partner in its rapidly growing Intellectual Property Group.

News Release

Schiff Hardin Recognized as a Recommended Firm by Benchmark Litigation

Schiff Hardin LLP has been ranked as a “Recommended Firm” in Illinois in the 2018 edition of Benchmark Litigation, an annual guide to the leading litigation firms and attorneys in the United States.

News Release

Schiff Hardin Recognized as a Top Hatch-Waxman Defense Firm

Schiff Hardin LLP has been recognized as one of the top law firms defending Abbreviated New Drug Application (ANDA) litigation in the 2017 Hatch-Waxman/ANDA Litigation Report compiled by legal data analytics firm Lex Machina.

News Release

Aly and Patel Named 2018 Life Sciences Stars

Imron Aly and Sailesh Patel have been named Life Sciences Stars in the Hatch-Waxman Patent Litigation Practice Area by LMG Life Sciences in its 2018 guide.

In The News
In The News
In The News
In The News
News Release

Chambers USA 2018 Recognizes Four Practice Areas and 22 Attorneys

Schiff Hardin is pleased to announce that four practice areas and 22 attorneys have been recognized in the 2018 edition of Chambers USA, a leading legal industry ranking.

In The News
News Release

Imron Aly Named a Leading Patent Litigator by IAM Patent 1000

Schiff Hardin is proud to announce that Intellectual Property Practice Group Co-Leader Imron Aly has been recognized in the seventh edition of IAM Patent 1000.

In The News
News Release

Schiff Hardin Named “Innovation Builder” by BTI

Schiff Hardin LLP has been singled out by corporate counsel as one of only 28 percent of law firms clients view as a BTI “Innovation Builder,” which recognizes firms that bring change to the legal market through new technology, services, strategies, or structures.

News Release

Schiff Hardin Recognized Among Managing Intellectual Property IP Stars

Schiff Hardin has been ranked as ‘Recommended’ by Managing Intellectual Property magazine in the Illinois IP Stars Patent Contentious category.

News Release

Schiff Hardin Secures Patent Infringement Win

Schiff Hardin successfully secured a favorable outcome for our client, Fresenius Kabi USA LLC, in a patent-infringement suit filed by Hospira Inc., which paves the way for Fresenius to market a new generic drug.

News Release

The Legal 500 Recognizes Three Schiff Hardin Practices for the Third Time in a Row

Schiff Hardin LLP is pleased to announce that three of its practice groups have been recognized for the third consecutive year by The Legal 500 United States 2018 guide, a nationwide analysis of law firms with input from more than 300,000 corporate counsel on which firms provide the most cutting-edge and innovative advice.

In The News
In The News
In The News
News Release

Aly Joins Center for Biosimilars Advisory Board

Intellectual Property Practice Group Co-Leader Imron Aly has joined the advisory board for the Center for Biosimilars, an online resource for emerging pharmaceutical biotechnology that discusses the current landscape for advanced health care management with top industry thought leaders.

In The News
News Release

Chambers USA 2019 Ranks 23 Attorneys, Four Practice Areas

Schiff Hardin is pleased to announce that four practice areas and 23 attorneys have been recognized in the 2019 edition of Chambers USA, a leading legal industry ranking.

News Release

George Yu Named to Law360 2019 Life Sciences Advisory Board

Partner George Yu has been selected for the Law360 2019 Life Sciences Editorial Advisory Board. According to Law360, the purpose of the nine-lawyer board is to gain insight from experts in the field on how best to shape future coverage.

News Release

IAM Patent 1000 Ranks Firm, Attorneys in Patent Litigation

Schiff Hardin LLP is proud to announce that the firm and three of its attorneys have been ranked in the eighth edition of IAM Patent 1000: The World’s Leading Patent Professionals.

News Release

Managing IP Recognizes Schiff Hardin Among IP Stars for Seventh Year

Schiff Hardin is pleased to announce that the firm has been ranked as ‘Recommended’ by Managing Intellectual Property magazine in the Illinois IP Stars Patent Contentious category, which includes dispute resolution work, litigation and enforcement, as well as Hatch-Waxman, International Trade Commission, and multinational litigation work.

In The News
News Release

Three Practices Recognized in The Legal 500 for Fourth Year in a Row

Schiff Hardin LLP is pleased to announce that three of the firm’s practice groups have been recognized for the fourth year in a row in The Legal 500 United States 2019 guide, which provides a nationwide analysis of law firms that provide cutting-edge and innovative advice.

Newsletter
Newsletter
Trending Legal Issue
Article
News Release

16 Schiff Hardin Lawyers Named to 2015 New York Metro Super Lawyers, Rising Stars Lists

Three Schiff Hardin attorneys were also recognized in New York Women’s Edition—Rising Stars.

Trending Legal Issue
Trending Legal Issue
Trending Legal Issue
Alert

Four Key Changes to the Antitrust Guidelines for Licensing of Intellectual Property—DOJ, FTC Invite Comments

Mark September 26, 2016, on your calendar as the deadline to tell the DOJ and FTC what should be changed, or not, in the Antitrust Guidelines for the Licensing of Intellectual Property.

Alert

Federal Circuit Rules The Lanham Act’s Disparagement Bar Unconstitutional, Creating A Circuit Split

The Court of Appeals for the Federal Circuit reversed over 30 years of precedent as it held unconstitutional the Section 2(a) disparagement bar of the Lanham Act on December 22, 2015.

Trending Legal Issue

Jurisdiction in the Information Age

Chapter 16 in Intellectual Property Law, IICLE (2017)

Alert

NDA Alert: Modify Your Non-Disclosure Agreements to Preserve All Remedies Under the New Federal Trade Secrets Statute

Recently enacted federal civil trade secret legislation immediately impacts the way non-disclosure agreements should be drafted.

Alert

No ‘Speeding Ticket’ for the PTAB

Supreme Court Holds that Decision to Institute IPR is Non-appealable and PTAB’s “Broadest Reasonable Construction” Standard for Claim Construction is Lawful

Alert

Pharma team scores rare preliminary injunction

Schiff Hardin’s pharma and life sciences patent litigation team, lead by partner Imron T. Aly, recently secured a preliminary injunction in federal court.

Article

Schiff Hardin Secures $2.6M Win for Warner Bros.

The Eighth Circuit affirmed a $2.57 million damages award and permanent injunction in favor of Warner Bros., protecting its copyrights and trademarks in The Wizard of Oz, Gone With the Wind, and Tom & Jerry cartoons.

Alert

The First Federal Civil Trade Secrets Law Is Now Effective

Trade secrets now enjoy the same type of federal protection afforded other forms of intellectual property, like trademarks, copyrights and patents.

Alert

Four Issues that Grabbed the U.S. Supreme Court’s Attention on Constitutionality of Inter Partes Review

IPRs have become a common, attractive tool for patent challengers because of their more favorable standard of review and one-year deadline to final written decision.

Alert

Pharma Giants in Antitrust Pricing Lawsuit over Biosimilars

Pfizer sued Johnson & Johnson (J&J) in federal court in Pennsylvania last week, alleging anticompetitive discounts and other actions to prevent competition with J&J’s biologic Remicade.

Alert

SCOTUS Decision Reaffirms Free Speech in Disparaging Trademarks

The U.S. Supreme Court’s Lee v. Tam decision struck down a provision of the federal trademark law.

Alert

Supreme Court Delivers Big Patent-Dance-Limiting Win for Biosimilars

Earlier this week, the U.S. Supreme Court unanimously held, in its first case interpreting the Biologics Price Competition and Innovation Act of 2009, Sandoz Inc. v. Amgen Inc.

Alert

Top 5 Antitrust Issues Facing Companies in the U.S. Today: #5 Intellectual Property

Decades ago, antitrust enforcement officials developed the “9 No-No’s” regarding patents and licenses. The days of antitrust hostility toward intellectual property are behind us, but renewed tension between antitrust and intellectual property policy seems to be growing.

Alert

Will The Supreme Court End Venue Shopping In Patent Cases?

The Supreme Court recently agreed to hear a challenge to the current interpretation of the venue statute in patent infringement cases.

In The News
Article
Alert

Four Key Issues to Watch in the U.S. Biosimilars Industry

Like generic drugs in the 1980s, biosimilars today face a number of regulatory, legal, scientific, and public perception obstacles to continued growth.

Blog Post

Generically Speaking: Liability is Limited in Failure to Warn Claims

Schiff Hardin Product Liability & Mass Torts Blog

Alert

Pharmaceutical and Technology Industry Innovation Growth at Stake in Helsinn Healthcare v. Teva

Today’s oral arguments in Supreme Court case Helsinn Healthcare v. Teva illustrate the power that a successful appeal could have to change a longstanding doctrine and significantly impact how businesses handle intellectual property transactions.

Article
Article
Article
Alert

U.S. Pharmaceutical and Biologics Industries Could See Steep Potential Consequences from Texas Judge’s ACA Decision

In the quick pound of a gavel, the entire U.S. pharmaceutical and biologics industries were thrown into doubt after Judge Reed O’Connor of the United States District Court for the Northern District of Texas found the individual mandate of the Affordable Care Act (ACA) – and therefore the entire act – unconstitutional.

Alert

How Pharmaceutical Companies Can Navigate FDA During Shutdown

As the government shutdown stretches on, pharmaceutical companies must manage the partial shutdown of the U.S. Food and Drug Administration (FDA).

Blog Post

Meritless Claims Create Inefficiencies in Multidistrict Litigation

Schiff Hardin Product Liability & Mass Torts Blog

Article

What if Pfizer Could Donate Data to NIH? One Proposal to Promote Public Good

Pfizer’s recent decision not to disclose data about Enbrel’s potential to treat Alzheimer’s disease has caused much debate about drugmakers’ obligations to the public.